Canadian Humira Post Marketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis

Study Identifier
P12-666
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Results Available

Scientific Result Summary
Available Language(s): English

Study Details

Medical Condition
  • Psoriatic Arthritis (PsA)
  • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18 - 99 Years

    Protocol Summary

    The current study will assess the real - life effectiveness of adalimumab in the management of articular and dermatological manifestations of moderate to severe Psoriatic Arthritis (PsA).

    Study Locations

    Location
    Status
    Location
    Pont, Cranbrook, BC, CA /ID# 69120
    Cranbrook, British Columbia, Canada, V1C 2R7
    Status
    Not applicable
    Location
    Dr. Barbara T. Blumenauer Inc. /ID# 75393
    Kamloops, British Columbia, Canada, V2C 0B8
    Status
    Not applicable
    Location
    Hudson, Kamloops, Canada /ID# 69104
    Kamloops, British Columbia, Canada, V2C 6G6
    Status
    Not applicable
    Location
    Dr. Maqbool R. Sheriff Inc. /ID# 69125
    Nanaimo, British Columbia, Canada, V9S 4S1
    Status
    Not applicable
    Location
    Carmi Medical Clinic /ID# 69128
    Penticton, British Columbia, Canada, V2A 3G7
    Status
    Not applicable
    Location
    Dr. J. Antonio Avina-Zubieta /ID# 71035
    Richmond, British Columbia, Canada, V6X 2C7
    Status
    Not applicable
    Showing {first} - {last} of {total} Results